Opinion
Significant Refundable R&D Offsets receipts reported to the ASX in recent months to January 2026
Over recent months, a number of companies have reported to the ASX receipt of substantial Refundable R&D Tax Offsets. Notable receipts include: Recce Pharmaceuticals (ASX: RCE) received $5.34 M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback